Can 18F-FES PET Improve the Evaluation of 18F-FDG PET in Patients With Metastatic Invasive Lobular Carcinoma?
Cheng Liu,Guang Ma,Xiaoping Xu,Shaoli Song,Zhongyi Yang
DOI: https://doi.org/10.1097/rlu.0000000000005085
IF: 10.6
2024-03-04
Clinical Nuclear Medicine
Abstract:Breast cancer represents the most prevalent malignant neoplasm and remains the foremost cause of mortality associated with cancer in women. 1 Breast cancer encompasses 2 primary histological types: the most prevalent form is invasive ductal carcinoma (IDC, accounting for 80% of breast cancers), followed by invasive lobular carcinoma (ILC, accounting for 10%–15% of breast cancers). 2,3 In comparison to IDC, ILC exhibits distinct oncological biological characteristics in terms of pathological features, clinical behavior, and metastasis patterns that significantly impact diagnosis and treatment strategies. 3–7 The loss of E-cadherin, a cell-cell adhesion molecule, represents the primary characteristic and diagnostic marker for ILCs. 8,9 The nonadherent cancer cells in ILCs exhibit augmented migratory and invasive potential as evidenced by their infiltrative diffusion pattern observed within various anatomical sites, including breast tissue, serosal surfaces, meninges, gastrointestinal tract, and ovaries. 10,11 Due to distinctive molecular mechanisms and clinical characteristics, ILC poses a greater challenge compared with IDC in imaging detection, which encompasses mammography, ultrasound, MRI, bone scans, and 18 F-FDG PET/CT. 12–17 Therefore, it is imperative to develop better imaging schemes for the assessment of local infiltration and distant metastasis in ILC.
radiology, nuclear medicine & medical imaging